Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Faravelli

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer|March 1, 1984
Carcinoembryonic antigen in pleural effusions. Diagnostic value in malignant mesotheliomaB Faravelli, E D'Amore, M Nosenzo, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|June 1, 1996
Evaluation of the impact of guidelines on tuberculosis control in Italy. National AIPO "Tuberculosis" Study Group. Associazione Italiana Pneumologi OspedalieriG B Migliori, L Casali, S Nardini, et al.
Tumori|February 28, 1987
Tissue polypeptide antigen (TPA) in pleural effusionsF Parazzi, B Faravelli, L Gallo, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1985
The role of concurrent determinations of pleural fluid and tissue carcinoembryonic antigen in the distinction of malignant mesothelioma from metastatic pleural malignanciesB Faravelli, M Nosenzo, A Razzetti, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|December 1, 1986
Adriamycin, cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancerA Ardizzoni, L Canobbio, P Pronzato, et al.
Cancer Treatment Reports|July 1, 1986
Etoposide and high-dose cisplatin in good-risk patients with advanced squamous cell carcinoma and adenocarcinoma of the lungA Ardizzoni, L Canobbio, P Pronzato, et al.
Anticancer Research|May 1, 1993
Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patientsV Fusco, A Ardizzoni, F Merlo, et al.
Anticancer Research|January 25, 2008
Maintenance therapy with gefitinib after first-line chemotherapy in patients affected by advanced non-small cell lung cancerM Mencoboni, M Bergaglio, M Serra, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer|March 1, 1984
Carcinoembryonic antigen in pleural effusions. Diagnostic value in malignant mesotheliomaB Faravelli, E D'Amore, M Nosenzo, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|June 1, 1996
Evaluation of the impact of guidelines on tuberculosis control in Italy. National AIPO "Tuberculosis" Study Group. Associazione Italiana Pneumologi OspedalieriG B Migliori, L Casali, S Nardini, et al.
Tumori|February 28, 1987
Tissue polypeptide antigen (TPA) in pleural effusionsF Parazzi, B Faravelli, L Gallo, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1985
The role of concurrent determinations of pleural fluid and tissue carcinoembryonic antigen in the distinction of malignant mesothelioma from metastatic pleural malignanciesB Faravelli, M Nosenzo, A Razzetti, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|December 1, 1986
Adriamycin, cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancerA Ardizzoni, L Canobbio, P Pronzato, et al.
Cancer Treatment Reports|July 1, 1986
Etoposide and high-dose cisplatin in good-risk patients with advanced squamous cell carcinoma and adenocarcinoma of the lungA Ardizzoni, L Canobbio, P Pronzato, et al.
Anticancer Research|May 1, 1993
Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patientsV Fusco, A Ardizzoni, F Merlo, et al.
Anticancer Research|January 25, 2008
Maintenance therapy with gefitinib after first-line chemotherapy in patients affected by advanced non-small cell lung cancerM Mencoboni, M Bergaglio, M Serra, et al.
Pageof 1